HEADER TRANSFERASE 09-MAR-18 6FXI TITLE HUMAN PARP10 (ARTD10), CATALYTIC FRAGMENT IN COMPLEX WITH 3- TITLE 2 AMINOBENZAMIDE AND CITRATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 10; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PARP-10,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 10, COMPND 5 ARTD10; COMPND 6 EC: 2.4.2.30; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP10; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC-BSA28 KEYWDS TRANSFERASE DOMAIN, ADP-RIBOSYLATION, PARP INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,H.SCHULER REVDAT 2 17-JAN-24 6FXI 1 REMARK REVDAT 1 20-MAR-19 6FXI 0 JRNL AUTH T.KARLBERG,A.G.THORSELL,H.SCHULER JRNL TITL HUMAN PARP10 (ARTD10), CATALYTIC FRAGMENT IN COMPLEX WITH JRNL TITL 2 3-AMINOBENZAMIDE AND CITRATE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 15113 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 756 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.78 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.47 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2694 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2505 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2559 REMARK 3 BIN R VALUE (WORKING SET) : 0.2488 REMARK 3 BIN FREE R VALUE : 0.2826 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3022 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 45 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.47140 REMARK 3 B22 (A**2) : 9.17980 REMARK 3 B33 (A**2) : -15.65120 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -10.39160 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.360 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.541 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.280 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.593 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.289 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.887 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.853 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3141 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4261 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1435 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 6 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 549 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3141 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 383 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3400 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.24 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 3.32 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -9.0415 21.3115 69.4993 REMARK 3 T TENSOR REMARK 3 T11: -0.1251 T22: -0.1437 REMARK 3 T33: 0.0510 T12: 0.0172 REMARK 3 T13: 0.0424 T23: 0.0021 REMARK 3 L TENSOR REMARK 3 L11: 2.2119 L22: 3.8474 REMARK 3 L33: 1.0524 L12: 2.3393 REMARK 3 L13: 0.2446 L23: -0.0473 REMARK 3 S TENSOR REMARK 3 S11: -0.1135 S12: 0.0179 S13: -0.3690 REMARK 3 S21: -0.1601 S22: 0.0256 S23: -0.5862 REMARK 3 S31: 0.0691 S32: 0.0823 S33: 0.0878 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -10.8504 51.6519 71.7283 REMARK 3 T TENSOR REMARK 3 T11: -0.0683 T22: -0.1269 REMARK 3 T33: -0.0346 T12: -0.0091 REMARK 3 T13: -0.0334 T23: -0.0061 REMARK 3 L TENSOR REMARK 3 L11: 2.4398 L22: 3.5883 REMARK 3 L33: 1.0308 L12: 2.0315 REMARK 3 L13: 0.0670 L23: 0.5299 REMARK 3 S TENSOR REMARK 3 S11: -0.2315 S12: 0.1006 S13: 0.2242 REMARK 3 S21: -0.3715 S22: 0.1834 S23: 0.0694 REMARK 3 S31: -0.1905 S32: -0.0246 S33: 0.0481 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FXI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009096. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15114 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 49.850 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.22300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.73700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5LX6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG3350, 0.1 M CITRATE-BIS-TRIS REMARK 280 -PROPANE, 3 MM 3-AMINOBENZAMIDE, PH 5.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.30000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 817 REMARK 465 SER B 817 REMARK 465 MET B 818 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 842 -118.68 50.74 REMARK 500 HIS A 858 78.51 -151.43 REMARK 500 PHE A 906 44.82 -96.93 REMARK 500 CYS A 907 0.79 -60.81 REMARK 500 ARG A 909 -97.83 13.34 REMARK 500 ASN A 910 -83.79 -135.02 REMARK 500 SER A 933 68.43 -112.81 REMARK 500 ASN A 936 -165.42 -77.83 REMARK 500 GLN A 984 78.61 67.57 REMARK 500 ASP B 842 -119.72 51.71 REMARK 500 HIS B 858 80.08 -150.64 REMARK 500 ARG B 909 -71.35 -20.37 REMARK 500 SER B 933 67.12 -113.18 REMARK 500 ASN B 936 -165.36 -79.19 REMARK 500 GLN B 984 77.84 69.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3AB A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CIT A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3AB B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CIT B 1102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5LX6 RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN OMPLEXED WITH VELIPARIB DBREF 6FXI A 819 1007 UNP Q53GL7 PAR10_HUMAN 819 1007 DBREF 6FXI B 819 1007 UNP Q53GL7 PAR10_HUMAN 819 1007 SEQADV 6FXI SER A 817 UNP Q53GL7 EXPRESSION TAG SEQADV 6FXI MET A 818 UNP Q53GL7 EXPRESSION TAG SEQADV 6FXI SER B 817 UNP Q53GL7 EXPRESSION TAG SEQADV 6FXI MET B 818 UNP Q53GL7 EXPRESSION TAG SEQRES 1 A 191 SER MET ASN LEU GLU ARG LEU ALA GLU ASN THR GLY GLU SEQRES 2 A 191 PHE GLN GLU VAL VAL ARG ALA PHE TYR ASP THR LEU ASP SEQRES 3 A 191 ALA ALA ARG SER SER ILE ARG VAL VAL ARG VAL GLU ARG SEQRES 4 A 191 VAL SER HIS PRO LEU LEU GLN GLN GLN TYR GLU LEU TYR SEQRES 5 A 191 ARG GLU ARG LEU LEU GLN ARG CYS GLU ARG ARG PRO VAL SEQRES 6 A 191 GLU GLN VAL LEU TYR HIS GLY THR THR ALA PRO ALA VAL SEQRES 7 A 191 PRO ASP ILE CYS ALA HIS GLY PHE ASN ARG SER PHE CYS SEQRES 8 A 191 GLY ARG ASN ALA THR VAL TYR GLY LYS GLY VAL TYR PHE SEQRES 9 A 191 ALA ARG ARG ALA SER LEU SER VAL GLN ASP ARG TYR SER SEQRES 10 A 191 PRO PRO ASN ALA ASP GLY HIS LYS ALA VAL PHE VAL ALA SEQRES 11 A 191 ARG VAL LEU THR GLY ASP TYR GLY GLN GLY ARG ARG GLY SEQRES 12 A 191 LEU ARG ALA PRO PRO LEU ARG GLY PRO GLY HIS VAL LEU SEQRES 13 A 191 LEU ARG TYR ASP SER ALA VAL ASP CYS ILE CYS GLN PRO SEQRES 14 A 191 SER ILE PHE VAL ILE PHE HIS ASP THR GLN ALA LEU PRO SEQRES 15 A 191 THR HIS LEU ILE THR CYS GLU HIS VAL SEQRES 1 B 191 SER MET ASN LEU GLU ARG LEU ALA GLU ASN THR GLY GLU SEQRES 2 B 191 PHE GLN GLU VAL VAL ARG ALA PHE TYR ASP THR LEU ASP SEQRES 3 B 191 ALA ALA ARG SER SER ILE ARG VAL VAL ARG VAL GLU ARG SEQRES 4 B 191 VAL SER HIS PRO LEU LEU GLN GLN GLN TYR GLU LEU TYR SEQRES 5 B 191 ARG GLU ARG LEU LEU GLN ARG CYS GLU ARG ARG PRO VAL SEQRES 6 B 191 GLU GLN VAL LEU TYR HIS GLY THR THR ALA PRO ALA VAL SEQRES 7 B 191 PRO ASP ILE CYS ALA HIS GLY PHE ASN ARG SER PHE CYS SEQRES 8 B 191 GLY ARG ASN ALA THR VAL TYR GLY LYS GLY VAL TYR PHE SEQRES 9 B 191 ALA ARG ARG ALA SER LEU SER VAL GLN ASP ARG TYR SER SEQRES 10 B 191 PRO PRO ASN ALA ASP GLY HIS LYS ALA VAL PHE VAL ALA SEQRES 11 B 191 ARG VAL LEU THR GLY ASP TYR GLY GLN GLY ARG ARG GLY SEQRES 12 B 191 LEU ARG ALA PRO PRO LEU ARG GLY PRO GLY HIS VAL LEU SEQRES 13 B 191 LEU ARG TYR ASP SER ALA VAL ASP CYS ILE CYS GLN PRO SEQRES 14 B 191 SER ILE PHE VAL ILE PHE HIS ASP THR GLN ALA LEU PRO SEQRES 15 B 191 THR HIS LEU ILE THR CYS GLU HIS VAL HET 3AB A1101 10 HET CIT A1102 13 HET GOL A1103 6 HET 3AB B1101 10 HET CIT B1102 13 HETNAM 3AB 3-AMINOBENZAMIDE HETNAM CIT CITRIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 3AB 2(C7 H8 N2 O) FORMUL 4 CIT 2(C6 H8 O7) FORMUL 5 GOL C3 H8 O3 FORMUL 8 HOH *45(H2 O) HELIX 1 AA1 THR A 827 THR A 840 1 14 HELIX 2 AA2 LEU A 841 ARG A 845 5 5 HELIX 3 AA3 HIS A 858 CYS A 876 1 19 HELIX 4 AA4 THR A 890 PRO A 892 5 3 HELIX 5 AA5 ALA A 893 GLY A 901 1 9 HELIX 6 AA6 ASN A 903 CYS A 907 5 5 HELIX 7 AA7 ARG A 923 VAL A 928 1 6 HELIX 8 AA8 THR B 827 THR B 840 1 14 HELIX 9 AA9 LEU B 841 ARG B 845 5 5 HELIX 10 AB1 HIS B 858 CYS B 876 1 19 HELIX 11 AB2 THR B 890 PRO B 892 5 3 HELIX 12 AB3 ALA B 893 GLY B 901 1 9 HELIX 13 AB4 ASN B 903 ASN B 910 5 8 HELIX 14 AB5 ARG B 923 VAL B 928 1 6 SHEET 1 AA1 5 LEU A 820 ARG A 822 0 SHEET 2 AA1 5 ILE A 848 VAL A 856 -1 O ARG A 855 N GLU A 821 SHEET 3 AA1 5 ALA A 996 HIS A1006 -1 O GLU A1005 N ARG A 849 SHEET 4 AA1 5 LYS A 941 VAL A 948 -1 N VAL A 943 O ILE A1002 SHEET 5 AA1 5 GLN A 883 THR A 889 -1 N LEU A 885 O ALA A 946 SHEET 1 AA2 4 VAL A 918 ALA A 921 0 SHEET 2 AA2 4 ILE A 987 ILE A 990 -1 O ILE A 990 N VAL A 918 SHEET 3 AA2 4 SER A 977 VAL A 979 -1 N ALA A 978 O VAL A 989 SHEET 4 AA2 4 TYR A 953 GLN A 955 1 N GLY A 954 O VAL A 979 SHEET 1 AA3 5 LEU B 820 ARG B 822 0 SHEET 2 AA3 5 ILE B 848 VAL B 856 -1 O ARG B 855 N GLU B 821 SHEET 3 AA3 5 ALA B 996 HIS B1006 -1 O GLU B1005 N ARG B 849 SHEET 4 AA3 5 LYS B 941 VAL B 948 -1 N LYS B 941 O CYS B1004 SHEET 5 AA3 5 GLN B 883 THR B 889 -1 N LEU B 885 O ALA B 946 SHEET 1 AA4 4 VAL B 918 ALA B 921 0 SHEET 2 AA4 4 ILE B 987 ILE B 990 -1 O ILE B 990 N VAL B 918 SHEET 3 AA4 4 SER B 977 VAL B 979 -1 N ALA B 978 O VAL B 989 SHEET 4 AA4 4 TYR B 953 GLN B 955 1 N GLY B 954 O VAL B 979 CISPEP 1 ARG A 879 PRO A 880 0 -2.14 CISPEP 2 ARG B 879 PRO B 880 0 -2.09 SITE 1 AC1 9 HIS A 887 GLY A 888 ARG A 909 PHE A 920 SITE 2 AC1 9 ALA A 921 LEU A 926 SER A 927 TYR A 932 SITE 3 AC1 9 ILE A 987 SITE 1 AC2 10 HIS A 887 THR A 889 ILE A 897 PHE A 902 SITE 2 AC2 10 ASN A 903 PHE A 906 ARG A 909 VAL A 918 SITE 3 AC2 10 HOH A1207 HOH A1210 SITE 1 AC3 4 HIS A 858 LEU A 860 HIS A 900 HIS B 992 SITE 1 AC4 10 HIS B 887 GLY B 888 ARG B 909 TYR B 919 SITE 2 AC4 10 PHE B 920 ALA B 921 LEU B 926 SER B 927 SITE 3 AC4 10 TYR B 932 ILE B 987 SITE 1 AC5 8 HIS B 887 THR B 889 ILE B 897 PHE B 902 SITE 2 AC5 8 ASN B 903 PHE B 906 ARG B 909 HOH B1212 CRYST1 51.600 86.600 57.460 90.00 104.98 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019380 0.000000 0.005186 0.00000 SCALE2 0.000000 0.011547 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018016 0.00000